Kevin Martin has over 35 years of FDA regulated industry experience that includes management positions at Wyeth and McNeil Pharmaceutical. He is considered a subject matter expert for lifesciences projects conducted within QA, IT, Manufacturing, Operations, Clinical and R&D environments. He is a frequent presenter at various industrial, professional, and trade associations on the subject of risk based systems validation and Part 11 compliance. He was a member of the PhRMA Computer Systems Validation Sub-Committee, was the Core Team Secretary for the PDA Part 11 Task Group and is currently Chair of the GAMP Americas Steering Committee. He received his Bachelors degree in Chemistry from Delaware Valley College of Science and Agriculture and his Master of Engineering in Manufacturing Systems from Penn State University.